Another side note is that he was also impeding the FDA approval process.<p>In order to get your generic approved you have to prove that it&#x27;s biologically equivalent to what&#x27;s on the market.  Shkreli&#x27;s distributor would only sell directly to end-users and would refuse to sell it to anyone doing equivalence studies on it.  Thus it was effectively impossible for anyone else to prove bioequivalence and bring a competing product to market.